Request Discount

Pharmerging Market (Product - Pharmaceuticals, and OTC Drugs; Indications - Lifestyle Diseases, Cancer and Autoimmune Diseases, and Others; Distribution Channel - Hospitals, Clinics, E-commerce, and Drug Stores Expenditure): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : August, 2019

  • Rep Id : HC0646

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Pharmerging Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Pharmerging Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Pharmerging Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on pharmerging market provides in-depth analysis of segments and sub-segments in the global as well as regional pharmerging market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional pharmerging market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global pharmerging market. According to the report, the global pharmerging market is projected to grow at a CAGR of 11.3% over the forecast period of 2019-2025.

Market Insight

The growing occurrence of non-transmissible illnesses is one of the major drivers driving the growth of the pharmerging market across the globe. An increase in the geriatric population, growing life expectancy are some other factors that drive the market growth. Furthermore, increasing healthcare expenditure, and constant research and developments are the key factors for the growth of pharmerging market. Besides, an increase in the number of private hospitals also fuels the growth of the market. However, high costs, socio-political issues in cross geography transactions, and IP protection issues are some of the major factors that may hamper the growth of the Pharmerging market during the forecast period. Moreover, a high focus on developing innovative drugs creates an opportunity for the growth of pharmerging market in the next few years.

In terms of region, the global pharmerging market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among all, the Asia Pacific is leading the pharmerging market due to rapid urbanization, growth in patent expiration. Furthermore, growing investments for medical research also boost market growth in the Asia Pacific region. China is leading the pharmerging market in the Asia Pacific region. This is attributed to the high population base and continuous research and developments in the pharmaceutical and medical and healthcare industries in China. Meanwhile, the Indian market is anticipated to be highly fragmented and competitive. Strategic planning, as well as new product launches, can help major pharmaceutical companies to be successful in this region. Europe and America are expected to grow at a beneficial rate over the forecast period. Technological advancements, advanced research and development practices, and the enhancing awareness relating to the management of healthcare facilities will boost the Latin America market. However, the Europe pharmerging market is expected to be driven by the increasing prevalence of chronic diseases, the presence of large population size, and the rise in health.

Segment Covered

The report on global pharmerging market covers segments such as product, indications, and distribution channel. On the basis of product, the sub-markets include pharmaceuticals, and otc drugs. On the basis of indications, the sub-markets include lifestyle diseases, cancer and autoimmune diseases, and others. On the basis of distribution channel, the sub-markets include hospitals, clinics, e-commerce, and drug stores expenditure.

Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories, Koninklijke Philips N.V., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, GlaxoSmithKline plc., and Sun Pharmaceutical Industries. 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of pharmerging market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount